AST SpaceMobile (ASTS) vs. Intuitive Machines (LUNR): Analysts Favor One Space Stock Over The Other In 2026

AST SpaceMobile (ASTS) and Intuitive Machines (LUNR) represent two of the most closely watched names in the rapidly expanding space infrastructure sector. AST SpaceMobile is building a space-based cellular broadband network designed to eliminate dead zones by connecting directly to standard consumer smartphones. The company has forged partnerships with roughly 60 mobile network operators, including…

Read More

IonQ (IONQ), Rigetti (RGTI), And D-Wave (QBTS) Face Off In A High-Stakes Quantum Computing Survival Race

Quantum computing stocks have generated enormous investor excitement, but the underlying financials tell a more complicated story about long-term viability. Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and IonQ (IONQ) rank among the most closely watched names in the sector, with share prices surging dramatically over the past three years. Despite the enthusiasm, most of these…

Read More

Invesco Aerospace and Defense ETF (NYSEARCA: PPA) Offers Single-Ticker Defense Exposure With Heavy Concentration at the Top

With defense budgets expanding sharply across the United States and Europe, the Invesco Aerospace and Defense ETF (NYSEARCA: PPA) has emerged as a popular single-trade option for investors seeking sector exposure. PPA holds 63 stocks spanning aerospace, defense, homeland security, and related technologies, giving it the appearance of a broadly diversified fund across the entire…

Read More

Quantum Computing Stocks IONQ, RGTI, And QBTS Face Q3 Pressure Despite Policy Tailwinds

As the third quarter nears its close, quantum computing stocks are caught between accelerating technological progress and persistent investor skepticism over commercialization timelines. IonQ (IONQ), Rigetti Computing (RGTI), and D-Wave Quantum (QBTS) have each announced significant developments since their second-quarter results, yet shares remain volatile and under pressure. The Federal Reserve raised its federal funds…

Read More

Novo Nordisk Licensing Deal Worth $1.33 Billion Sends Nanexa (NANEXA) Stock Surging Over 120%

Novo Nordisk (NVO) has struck a major licensing agreement with Swedish drug-delivery firm Nanexa just days after a disappointing capital-markets event rattled investor confidence. Shares in Uppsala-based Nanexa more than doubled in early Friday trading after the global licensing deal, valued at up to approximately €1.17 billion ($1.33 billion), was announced. Novo Nordisk’s U.S.-listed shares…

Read More